Recent Articles from GlobeNewswire
Norwood Financial Corp announces Third Quarter Financial Results
Quarterly Highlights:
By Norwood Financial Corp · Via GlobeNewswire · October 27, 2026
Wave Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business Update
Planning underway for registrational trial of WVE-006 (RNA editing) in AATD, with an interim analysis for potential accelerated approval based on AATD biomarkers
By Wave Life Sciences USA, Inc. · Via GlobeNewswire · October 27, 2026
FTI Consulting Adds Neel Malkani to Help Private Capital Firms and Portfolio Companies Accelerate Value Creation
Private equity operations expert brings more than 20 years of experience helping investors and portfolio companies improve EBITDA, optimize operations and accelerate enterprise value creation
By FTI Consulting, Inc. · Via GlobeNewswire · October 27, 2026
Hubbell Reports Third Quarter 2026 Results
Shelton, CT, Oct. 27, 2026 (GLOBE NEWSWIRE) --
By Hubbell Inc. · Via GlobeNewswire · October 27, 2026
InflaRx Announces November Investor Events
Jena, Germany, Oct. 27, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its events calendar for November.
By InflaRx N.V. · Via GlobeNewswire · October 27, 2026
Medicus Pharma to Present at BioFuture and Global Biotechnology Summit
Company’s Executive Chairman and CEO to Speak on Cancer Therapeutics Spotlight Panel at BioFuture in NYC and Deliver Keynote Address at Global Biotechnology Summit in Abu Dhabi
By Medicus Pharma Ltd · Via GlobeNewswire · October 27, 2026
Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET
HOLLISTON, Mass., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2026, before the market opens on November 10, 2026, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
By Harvard Bioscience, Inc. · Via GlobeNewswire · October 27, 2026
OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel
Latest DSP integration expands buyer access to OptimizeRx point of care inventory through existing programmatic workflows
By OptimizeRx Corporation · Via GlobeNewswire · October 27, 2026
Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK®
SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva or the Company), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases, today announced that it will discontinue further development of AlloNK® (AB-101), its non-genetically modified, allogeneic NK cell therapy candidate being evaluated in combination with rituximab in rheumatoid arthritis (RA) and other B-cell-driven autoimmune diseases. The decision follows the Company’s review of the overall risk-benefit in the context of updated clinical data, including longer-term follow-up, and recent Grade 5 safety events. The Company also announced that it is implementing a reduction in workforce and evaluating strategic alternatives to maximize stockholder value that may include a merger, business combination, sale or licensing of assets, or dissolution and liquidation.
By Artiva Biotherapeutics, Inc. · Via GlobeNewswire · October 27, 2026
Weatherford Announces Court Approval and Expected Closing Date for U.S. Redomestication
HOUSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced that the High Court of Ireland has approved the previously announced scheme of arrangement through which the Company intends to change its legal domicile from Ireland to Delaware.
By Weatherford US Holding, LLC · Via GlobeNewswire · October 27, 2026
Lumion Highlights AI Agents for After-Hours Inquiries and Lead Follow-Up
SALT LAKE CITY, UTAH, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Lumion is outlining its approach to business automation through AI agents designed to manage customer inquiries, support automated follow-up, and reconnect with prospective customers. The company's platform brings together AI-powered communication, workflow automation, and a unified inbox to help organizations coordinate customer interactions across calls, text messages, and website inquiries.
By Lumion · Via GlobeNewswire · October 27, 2026
Flow Capital Announces Trading Symbol Change to “FLOW”
TORONTO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Flow Capital Corp. (“Flow Capital” or the “Company”) (CSE: FW), a leading provider of flexible growth capital and alternative debt solutions for high-growth companies, is pleased to announce that its common shares will begin trading on the Canadian Securities Exchange (the “CSE”) under the new ticker symbol “FLOW”, effective at market open on October 29, 2026.
By Flow Capital Corp. · Via GlobeNewswire · October 27, 2026
Cellectar Biosciences Reports Case Study Highlighting Complete Response Lasting More Than Eight Years in Heavily Pretreated DLBCL Patient Treated with Iopofosine I 131
Durable Complete Response Achieved with Single Administration of Iopofosine I 131
By Cellectar Biosciences, Inc. · Via GlobeNewswire · October 27, 2026
AI Readiness Drives Organizational Impact
White River Strategy launches its Social Sector AI Readiness Report, Highlighting the Need to Move Beyond Individual AI Usage and Embrace Organizational AI Integration
By White River Strategy · Via GlobeNewswire · October 27, 2026
RecycLiCo and Alaska Energy Metals Collaborate to Test Proprietary Processing Methods on the Polymetallic Eureka Deposit, Nikolai Nickel Project, Alaska
VANCOUVER, British Columbia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. (“RecycLiCo”) (TSX.V: AMY | OTCQB: AMYZF | FSE: ID4), a critical mineral refining and lithium-ion battery upcycling company, and Alaska Energy Metals Corp. (“AEMC”) (TSX.V: AEMC | OTCQB: AKEMF | FRA: V7F) are pleased to announce the commencement of testing of metal concentrate samples derived from drill core from the 2023-2024 exploration campaigns at the polymetallic Eureka deposit, located at AEMC’s Nikolai Nickel Project in Alaska. The work is being done at RecycLiCo’s laboratory in Delta, BC, in accordance with a protocol prepared by RecycLiCo and approved by AEMC. Testing is in furtherance of the previously announced memorandum of understanding (“MOU”) between AEMC and RecycLiCo’s U.S. subsidiary to assess the ways in which RecycLiCo’s hydrometallurgical processing technology could be used in refining the output from the Eureka deposit, which contains seven U.S. Government-designated Critical Minerals, including nickel, cobalt, copper, chromium, platinum, palladium, and gold (along with the non-critical mainstay metal iron). Recently reported locked cycle flotation results have proven strong recoveries of metals reporting to a bulk nickel-copper concentrate. AEMC is exploring multiple avenues for hydrometallurgical testing to determine the optimum extraction technique to achieve the highest value from downstream processing of the bulk concentrate.
By RecycLiCo Battery Materials · Via GlobeNewswire · October 27, 2026
Mammogen and MammoLink Partner to Advance a New Model for Community-Based Breast Cancer Detection
MammoLink joins Mammogen’s KATELYN-ERIN trial, expanding community access to a prospective study evaluating blood-based RNA biology for breast cancer detection
By Mammogen, Inc. · Via GlobeNewswire · October 27, 2026
Cullinan Therapeutics Advances Velinotamig into Global Clinical Development for Autoimmune Cytopenias Following IND Clearance by the U.S. FDA
Global regulatory clearances in the U.S. and Australia support initiation of a Phase 1b/2a study in relapsing and refractory ITP and wAIHA
By Cullinan Therapeutics, Inc. · Via GlobeNewswire · October 27, 2026
TransMedics selects Gogo Galileo HDX for nationwide organ transport fleet
Reliable, high-performance connectivity will support time-critical transport and monitoring of donor organs for transplants aboard 22 Embraer Phenom 300E aircraft
By Gogo · Via GlobeNewswire · October 27, 2026
Fortrea to Participate in Jefferies Global Healthcare Conference
DURHAM, N.C., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor Relations Tracy Krumme will participate in the following conference:
By Fortrea Holdings Inc · Via GlobeNewswire · October 27, 2026
GXO Opens Strategic Logistics Hub in Malaysia to Support Growth Across Asia Pacific
Located in the Johor-Singapore Special Economic Zone, the Medini site expands GXO’s presence in Asia Pacific and provides enhanced flexibility across regional supply chains
By GXO Logistics · Via GlobeNewswire · October 27, 2026
Osisko Gold Provides Construction Progress Update on the Cariboo Gold Project
(All dollar amounts are expressed in Canadian dollars, unless stated otherwise)
By Osisko Gold Group Inc. · Via GlobeNewswire · October 27, 2026
Iovance Biotherapeutics to Report Third Quarter 2026 Financial Results and Corporate Updates on Thursday, November 5, 2026
PHILADELPHIA, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, will host a conference call and live audio webcast on Thursday, November 5, 2026 at 8:30 a.m. ET to report its third quarter 2026 financial results and corporate updates.
By Iovance Biotherapeutics, Inc. · Via GlobeNewswire · October 27, 2026
Factorial Sets Date for Third Quarter 2026 Results
BOSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Factorial Energy Inc. (“Factorial”) (Nasdaq: FAC), a global leader in solid-state battery technology, today announced it will release financial results for the third quarter 2026 after the market closes on Tuesday, November 10, 2026. Management will host a webcast and conference call that same day at 4:30 PM ET to review results.
By Factorial Inc. · Via GlobeNewswire · October 27, 2026
CoinShares Board Approve $40 Million Share Repurchase Program
JERSEY, Channel Islands, 27th October 2026 - CoinShares PLC (Nasdaq: CSHR) (“CoinShares” or the “Company”) today announced that its Board of Directors has approved a program to repurchase up to $40 million of the Company’s ordinary shares, pursuant to the shareholder authority granted at the 15th of September 2026 Extraordinary General Meeting. The program will remain authorised until the Company’s next Annual General Meeting, expected in Q2 2027.
By CoinShares PLC · Via GlobeNewswire · October 27, 2026
Luckin Coffee to Announce Third Quarter 2026 Financial Results on November 3, 2026
BEIJING, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) will release its third quarter 2026 financial results before the U.S. market opens on Tuesday, November 3, 2026.
By Luckin Coffee Inc. · Via GlobeNewswire · October 27, 2026
Marex appoints Kory Sorenson to Group Board
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Marex Group Limited (‘Marex’ or the ‘Group’, NASDAQ: MRX), the diversified global financial services platform, today announces that Kory Sorenson will join the Group Board with effect from 2 November 2026.
By Marex Group Limited · Via GlobeNewswire · October 27, 2026
SunPower Expands in Texas with SOLRITE Virtual Power Plant Partnership
OREM, Utah, Oct. 27, 2026 (GLOBE NEWSWIRE) -- SunPower Inc. (“SunPower,” or the “Company”)(Nasdaq SPWR), a solar technology, services, and installation company, today announced an expansion in Texas through the acquisition of prime project assets from Houston installer Greenlight Solar, as well as a second strategic partnership with Fort Worth financier SOLRITE Energy to expand its residential solar and storage offerings and accelerate its Virtual Power Plant (VPP) business in which residential and commercial batteries can sell power.
By SunPower Inc. · Via GlobeNewswire · October 27, 2026
Adagene to Participate in the Guggenheim Securities 3rd Annual Healthcare Innovation Conference
SAN DIEGO and SUZHOU, China, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced that senior management will participate in a fireside chat and one-on-one meetings at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference being held November 9-11, 2026 in Boston, MA.
By Adagene Inc. · Via GlobeNewswire · October 27, 2026
MEGL Enters into Strategic Cooperation with Singapore’s SIN HOPEWAY for USD 500 Million Timber Trade
Hong Kong, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Magic Empire Global Limited (“MEGL” or the “Company”) today announced that on October 22, 2026, it entered into a letter of intent (the “Letter of Intent”) with Singapore-based commodity trading enterprise SIN HOPEWAY PTE. LTD., for a five year strategic cooperation to develop an international timber import and export supply chain business, commencing from the date of the Letter of Intent. During the five-year cooperation period, the Company, having completed its strategic industrial upgrade, shall supply SIN HOPEWAY PTE. LTD. with raw timber materials. The cumulative target trade volume between the parties shall be US$500 million.
By Magic Empire Global Limited · Via GlobeNewswire · October 27, 2026
Ashland sets date for fourth-quarter fiscal 2026 earnings release and conference call webcast
WILMINGTON, Del., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter fiscal 2026 earnings release at approximately 5 p.m. ET on Tuesday, November 3, 2026. The company’s live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Wednesday, November 4. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com.
By Ashland, Inc. · Via GlobeNewswire · October 27, 2026
Aeluma to Participate in Upcoming Investor Conferences
GOLETA, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, announced today that it will participate in the following upcoming investor conferences:
By Aeluma, Inc. · Via GlobeNewswire · October 27, 2026
Beam Therapeutics Reports Initial Clinical Data from Phase 1/2 Trial of BEAM-301, Demonstrating Proof of Concept for Genetic Correction in Glycogen Storage Disease Type Ia (GSDIa) at ESGCT 33rd Annual Congress
In the 40 mg Cohort, Two Patients Achieved 15 Hours of Controlled Fasting, Improvements in Glucose Control and No Longer Required Starch Supplementation Following Treatment
By Beam Therapeutics · Via GlobeNewswire · October 27, 2026
Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026
DURHAM, N.C., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2026 after the market closes on Monday, November 2, 2026. The Company’s management will host a conference call at 4:30 p.m. Eastern Time that same day to discuss the results and provide a business update.
By Bioventus, Inc. · Via GlobeNewswire · October 27, 2026
Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026
NEW HAVEN, Conn., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review third quarter 2026 financial results and provide a corporate update during a live webcast on Tuesday, November 3, 2026 at 8:00 a.m. ET.
By Arvinas Inc. · Via GlobeNewswire · October 27, 2026
Aquestive Therapeutics to Report Third Quarter 2026 Financial Results and Recent Business Highlights on November 3 and Host Conference Call on November 4 at 8:00 a.m. ET
WARREN, N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a biopharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report financial results for the third quarter ended September 30, 2026, and provide an update on recent developments in its business after market close on Tuesday, November 3, 2026.
By Aquestive Therapeutics, Inc. · Via GlobeNewswire · October 27, 2026
ButcherBox Takes a Stand on Antibiotics in School Meals on Capitol Hill
Direct-to-consumer meat brand gathers supporters calling on USDA to make ‘No Antibiotics Ever’ chicken available in cafeterias across the country
By ButcherBox · Via GlobeNewswire · October 27, 2026
Herschel Parts Automates Multicarrier Shipping and Improves Cost Control with Descartes
ATLANTA, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Herschel Parts, a global manufacturer and distributor of aftermarket agricultural replacement parts to businesses and consumers, is using the Descartes Pacejet™ multicarrier shipping solution integrated with its enterprise resource planning (ERP) system. Herschel is processing 98% of its shipments through one workflow spanning parcel and less-than-truckload (LTL) carriers. By consolidating shipping workflows and carrier rating, Herschel has eliminated approximately 10 hours per week of manual data entry, gained immediate shipment visibility and identified carrier options that can be 5% to 10% less expensive for individual shipments.
By The Descartes Systems Group Inc · Via GlobeNewswire · October 27, 2026
DNOW Announces Third Quarter 2026 Earnings Conference Call
HOUSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- DNOW Inc. (NYSE:DNOW) has scheduled a conference call to discuss the results for the third quarter of 2026 on Thursday, November 5, 2026 at 8:00 am (US Central Time). Financial results for the third quarter ending September 30, 2026 are expected to be released that morning before the market opens.
By DNOW L.P. · Via GlobeNewswire · October 27, 2026
Marathon Feet Trace China Tianjin's Stories as 30,000 Runners Hit the Streets
The Bank of Tianjin Tianjin Marathon 2026
By The Bank of Tianjin Tianjin Marathon 2026 · Via GlobeNewswire · October 27, 2026
INNIO Reports Record Third Quarter 2026 Financial Results with Revenue Up 57%, Net Income Up 176% and Adjusted EBITDA Up 70%; Raises 2026 Full-Year Guidance
Third Quarter 2026 Financial Highlights
By INNIO N.V. · Via GlobeNewswire · October 27, 2026
Merakris Advances Potentially Pivotal MTX-001 Phase 2/3 Strategy Following FDA Pre-IND Meeting
FDA indicates proposed double-blind Phase 2/3 design could be considered adequate and well controlled as Merakris prepares its first commercial-pilot GMP drug lot for a potentially pivotal trial.
By Merakris Therapeutics · Via GlobeNewswire · October 27, 2026
Sigenergy Unveils SigenCube at Exclusive Melbourne VIP Gala Ahead of All-Energy Australia 2026
MELBOURNE, Australia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- On the eve of All-Energy Australia 2026, Sigenergy hosted an exclusive VIP Party in Melbourne, welcoming over 600 industry partners, major distributors, certified installers, and clean energy leaders. The landmark evening served as the official global launch for SigenCube, Sigenergy's All-in-One Commercial & Industrial (C&I) Energy Solution.
By Sigenergy · Via GlobeNewswire · October 27, 2026
Nautilus Biotechnology Reports Third Quarter 2026 Financial Results
SEATTLE, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2026.
By Nautilus Biotechnology Inc. · Via GlobeNewswire · October 27, 2026
Anteris Announces Upcoming Data Release for Medium-Size DurAVR THV from EMBARK Study at TCT 2026
MINNEAPOLIS and BRISBANE, Australia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) today announced that Azeem Latib, MD, will present the first 30-day clinical and hemodynamic outcomes for its medium-size DurAVR® Transcatheter Heart Valve (THV) at TCT® 2026 – The 38th Annual Transcatheter Cardiovascular Therapeutics Conference, taking place in San Diego, California, October 31-November 3, 2026.
By Anteris Technologies Global Corp. · Via GlobeNewswire · October 27, 2026
Nautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS Consortium
Nautilus expects to receive up to $6 million to bring its Voyager™ Platform to a multidisciplinary team integrating protein science, AI, and computational modeling to develop new diagnostics and therapeutics
By Nautilus Biotechnology Inc. · Via GlobeNewswire · October 27, 2026
Atour Lifestyle Holdings Limited to Report Third Quarter 2026 Financial Results on November 10, 2026
SHANGHAI, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading lifestyle group in China, today announced that it will report its unaudited financial results for the third quarter 2026 on Tuesday, November 10, 2026, before the U.S. markets open.
By Atour Lifestyle Holdings Limited · Via GlobeNewswire · October 27, 2026
T1 Energy Announces Third Quarter 2026 Earnings Release and Conference Call Schedule
AUSTIN, Texas and NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) announced this morning that the Company will publish a press release detailing third quarter 2026 results and conduct a conference call on Thursday, November 12, 2026.
By T1 Energy Inc. · Via GlobeNewswire · October 27, 2026
Titan Mining to Host Q3 2026 Update Call on November 12, 2026
GOUVERNEUR, N.Y., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Titan Mining Corporation (NYSE-A:TII, TSX:TI), (“Titan” or the “Company”), a U.S.-focused critical minerals producer and developer, will release its third quarter 2026 financial results before market open on Thursday, November 12, 2026, and host a quarterly corporate update conference call the same day.
By Titan Mining Corporation · Via GlobeNewswire · October 27, 2026
Immuron continued quarterly sales growth
Sales Highlights (unaudited):
By Immuron Limited · Via GlobeNewswire · October 27, 2026
Enerflex Ltd. Announces Appointment of New Independent Directors
CALGARY, Alberta, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) announces the appointment of Mr. David Primrose and Ms. Mary Zappone to its Board of Directors (the “Board”), effective today. Mr. Primrose has also been appointed as a member of the Audit Committee.
By Enerflex Ltd. · Via GlobeNewswire · October 27, 2026
MEXC and Hacken Launch AI Trading Safety Handbook to Promote Safer AI Adoption
By MEXC · Via GlobeNewswire · October 27, 2026
Space-Saving, Ultra-Quiet, and Powerful: Sigenergy Launches the SigenCube C&I BESS
MELBOURNE, Australia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Sigenergy, a global leader in AI-driven smart solar and energy storage solutions, today officially unveiled the SigenCube Commercial & Industrial Battery Energy Storage System (C&I BESS) ahead of All-Energy Australia 2026. Designed to address the core challenges of commercial deployments—such as limited space, noise restrictions, and heavy power demands—the SigenCube introduces industry-leading energy density, ultra-quiet operation, and robust overload performance to the global market.
By Sigenergy · Via GlobeNewswire · October 27, 2026
Octave Alto expands visualization capabilities
Latest update allows single, consolidated visualization of multiple mission-critical data sources
By Octave Intelligence plc · Via GlobeNewswire · October 27, 2026
iQIYI to Report Third Quarter 2026 Financial Results on November 16, 2026
BEIJING, Oct. 27, 2026 (GLOBE NEWSWIRE) -- iQIYI, Inc. (NASDAQ: IQ) ("iQIYI" or the "Company"), a leading provider of online entertainment video services in China, today announced that it will report its financial results for the third quarter ended September 30, 2026 before the U.S. market opens on November 16, 2026.
By iQIYI, Inc. · Via GlobeNewswire · October 27, 2026
Smithfield Foods Reports Third Quarter Results
SMITHFIELD, Va., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Smithfield Foods, Inc. (Nasdaq: SFD), an American food company and an industry leader in value-added packaged meats and fresh pork, today reported results for its fiscal 2026 third quarter ended September 27, 2026.
By Smithfield Foods, Inc. · Via GlobeNewswire · October 27, 2026
Proof That Travels: ADI Foundation and SAGINT Partner to Bring Verified Origin to Every Lot of Critical Minerals Worldwide
ABU DHABI, United Arab Emirates and AUSTIN, Texas, Oct. 27, 2026 (GLOBE NEWSWIRE) -- ADI Foundation, an institutional gateway enabling public and private sector organizations to adopt blockchain technology and SAGINT®, a digital asset developer transforming tangible assets into tradable tokens, today announced a global partnership to bring SAGINT’s Digital Warehouse Receipt technology to ADI Chain, creating a verifiable digital record for critical minerals as they move from producer to warehouse, buyer and across borders.
By ADI Foundation · Via GlobeNewswire · October 27, 2026
Political Uncertainty Fuels Demand for Additional Residence and Citizenship Rights
LONDON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- New data shows a rising interest in additional residence and citizenship rights among wealthy families in some of the world's most established countries, as political, regulatory and social volatility sharpens the focus on resilience and future optionality.
By HENLEY & PARTNERS GROUP HOLDINGS LTD · Via GlobeNewswire · October 27, 2026
Bending Spoons announces proposed offering of senior secured notes
MILAN, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Bending Spoons S.p.A. (“Bending Spoons”) today announced the proposed offerings of $1.5 billion (approximate equivalent) senior secured notes, subject to market and other conditions. The offerings are composed of $1 billion aggregate principal amount of U.S. dollar-denominated senior secured notes and $500 million (approximate equivalent) of euro-denominated senior secured notes (together, the “Notes”), both due in 2032.
By Bending Spoons S.p.A. · Via GlobeNewswire · October 27, 2026
Fangzhou’s AI-Powered Supply Chain Platform Recognized in 2026 for Pharmaceutical Distribution Best Practices
GUANGZHOU, China, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, was recently recognized for its AI-powered pharmaceutical procurement and inventory management platform, which was included in the 2026 Collection of Best Practices for High-Quality Pharmaceutical Distribution Development, highlighting the Company's innovation in digital supply chain management.
By Fangzhou Inc. · Via GlobeNewswire · October 27, 2026
Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), a genome engineering company developing genetic medicines for diseases that today demand a lifetime of treatment, today announced the presentation of preclinical data supporting .HEAL-101, its in vivo base editing product candidate targeting APOC3 for severe hypertriglyceridemia (sHTG), at the Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), being held October 27-30, 2026, in Hamburg, Germany.
By Cellectis Inc. · Via GlobeNewswire · October 27, 2026
Recover™ Launches REAL: A Global Campaign Celebrating Solutions That Deliver Today
REAL. Today, Not Someday.
By Recover™ · Via GlobeNewswire · October 27, 2026
ING completes share buyback programme
ING completes share buyback programme
By ING Group · Via GlobeNewswire · October 27, 2026
ONWARD Medical to Announce Third-Quarter 2026 Results on November 3, 2026
EINDHOVEN, The Netherlands, Oct. 27, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announced that it will release its third-quarter 2026 financial results and host a webcast with a comprehensive business update on November 3, 2026.
By ONWARD Medical NV · Via GlobeNewswire · October 27, 2026
Publication of the Q3 2026 financial results on Tuesday, November 3, 2026, after market close
Paris, France – October 27, 2026
By Viridien · Via GlobeNewswire · October 27, 2026
Intermountain Health Groundbreaking on a New Era of Children’s Health for Nevada
Nevada’s first stand-alone children’s hospital groundbreaking marks the community-wide effort to build a stronger pediatric health system.
By Intermountain Children's Heatlh · Via GlobeNewswire · October 27, 2026
Syncron Expands conet Partnership to Strengthen Aftermarket Pricing and Planning Delivery Across EMEA
VAR agreement supports Syncron’s partner strategy by combining regional consulting expertise with certified Syncron implementation capabilities
By Syncron Inc · Via GlobeNewswire · October 27, 2026
Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November
Leiden, the Netherlands, October 27, 2026: Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR), a global biotechnology company focused on rare immune and genetic diseases, presents its preliminary (unaudited) financial report for the three months ended September 30, 2026.
By Pharming Group N.V. · Via GlobeNewswire · October 27, 2026
Basilea raises full-year guidance 2026 and financial target for “Agenda 2030” and provides updates on late-stage clinical programs
Ad hoc announcement pursuant to Art. 53 LR
By Basilea Pharmaceutica International Ltd, Allschwil · Via GlobeNewswire · October 27, 2026
ROOT Brands and OptimalMD Launch New Corporate Wellness Initiatives
Founders Clayton Thomas and Dr. Christina Rahm spearhead a new era of employee benefits and preventative care
By The ROOT Brands · Via GlobeNewswire · October 27, 2026
FTI Consulting Continues Growth of Middle East Tax Practice With Appointment of Sandeep Kumar as Senior Managing Director
Senior appointment strengthens UAE corporate and international tax leadership to help clients navigate complex corporate and international tax requirements
By FTI Consulting, Inc. · Via GlobeNewswire · October 27, 2026
Omni Bridgeway Makes Strong Start to FY27 with 3.9x MOIC on Completions and US$1 Billion Series II Final Close
SYDNEY, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Omni Bridgeway Limited (ASX: OBL), a leading global alternative asset manager specialising in legal assets, has released its Investment Portfolio Report as at 30 September 2026 (1Q27). The first quarter of the financial year (FY27) delivered elevated completion returns, 24% growth in management fees and the final close of Funds 4/5 Series II at its full US$1 billion target, with the Group tracking at or above all of its FY27 operational targets.
By Omni Bridgeway · Via GlobeNewswire · October 26, 2026
Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
CARY, N.C., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, November 9, 2026, at 8:30 a.m. ET to report third quarter financial results and discuss recent business highlights.
By Heron Therapeutics, Inc. · Via GlobeNewswire · October 26, 2026
Save the Date: HUTCHMED to Host Expert Insights Event on Recent Savolitinib Clinical Data in Non-Small Cell Lung Cancer
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 26, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces an expert webcast, co-hosted with Citigroup Global Markets Asia Limited (“Citigroup”) for analysts and investors, to discuss recent Phase III clinical data for savolitinib in MET-driven non-small cell lung cancer (“NSCLC”) recently presented at the European Society for Medical Oncology (ESMO) Congress 2026. This virtual webcast will take place on Thursday, November 5, 2026, at 4:30 pm HKT / 8:30 am GMT / 3:30 am EST.
By HUTCHMED (China) Limited · Via GlobeNewswire · October 26, 2026
ROSEN, THE FIRST FILING FIRM, Encourages Tigo Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TYGO
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · October 26, 2026
Pomona College and Claremont Graduate University Deepen Century-Long Ties Through New Strategic Partnership
The affiliation agreement between the adjoining campuses, both part of The Claremont Colleges consortium, builds on the shared legacy between Pomona and CGU.
By Pomona College · Via GlobeNewswire · October 26, 2026
